3rd Quarter - Report

MCDERMOTT+ LLC for CLINICAL LABORATORY FEE SCHEDULE REFORM COALITION

Firm
Client
Income
$100,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues concerning regulation of laboratory tests.

Foreign entity interest: The foreign entities identified on Form LD-1 have ownership interests in the subsidiaries that participate in this Coalition, and would be affected financially by changes to Medicare payment for certain laboratory tests.

LobbyistCovered position, as disclosed
ANDREA BERGMAN Michael Crapo
PAUL RADENSKY —
ERIC ZIMMERMAN —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB)

Medicare/Medicaid MMM

Medicare reimbursement for laboratory tests.

Foreign entity interest: The foreign entities identified on Form LD-1 have ownership interests in the subsidiaries that participate in this Coalition, and would be affected financially by changes to Medicare payment for certain laboratory tests.

LobbyistCovered position, as disclosed
ANDREA BERGMAN Michael Crapo
PAUL RADENSKY —
ERIC ZIMMERMAN —

Contacted: SENATE; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Medical/Disease Research/Clinical Labs MED

Issues concerning regulation of laboratory tests.

Foreign entity interest: The foreign entities identified on Form LD-1 have ownership interests in the subsidiaries that participate in this Coalition, and would be affected financially by changes to Medicare payment for certain laboratory tests.

LobbyistCovered position, as disclosed
ANDREA BERGMAN Michael Crapo
PAUL RADENSKY —
ERIC ZIMMERMAN —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.